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ABSTRACT: Transport of hydrophilic di- and tripeptides into Lactococcus lactis is mediated by a proton
motive force-driven peptide transport protein (DtpT) that shares similarity with eukaryotic peptide
transporters, e.g., from kidney and small intestine of rabbit, man, and rat. Hydropathy profiling in
combination with the “positive inside rule” predicts for most of the homologous proteins an R-helical
bundle of 12 transmembrane segments, but the positions of these transmembrane segments and the location
of the amino and carboxyl termini are by no means conclusive. The secondary structure of DtpT was
investigated by analyzing 42 DtpT-alkaline phosphatase fusion proteins, generated by random or directed
fusions of the corresponding genes. These studies confirm the presence of 12 transmembrane segments
but refute several other predictions made of the secondary structure. Data obtained from the fusion proteins
were substantiated by studying the accessibility of single cysteine mutants in putative cytoplasmic or
extracellular loops by membrane (im)permeant sulfhydryl reagents. The deduced topology model of DtpT
consists of a bundle of 12 R-helixes with a short amino and a large carboxyl terminus, both located at the
cytoplasmic site of the membrane. On the basis of sequence comparisons with DtpT, it seems likely that
the structure model of the amino-terminal half of DtpT also holds for the eukaryotic peptide transporters,
whereas the carboxyl-terminal half is largely different.
The di- and tripeptide transport system (DtpT)1 of Lac-
tococcus lactis is an integral membrane protein that mediates
transport of hydrophilic di- and tripeptides in symport with
protons. Transport of the more hydrophobic di- and tri-
peptides is catalyzed by another di- and tripeptide transport
system DtpP (Foucaud et al., 1995). This transport is ATP-
driven, like the uptake of peptides of more than three amino
acid residues via the oligopeptide transport system Opp
(Kunji et al., 1995). Like other known prokaryotic peptide
transporters for which gene sequences are available, the Opp
system, and most likely DtpP as well, belongs to the ATP-
binding cassette (ABC) superfamily of transport proteins,
also referred to as traffic ATPases (Higgins, 1992). In
contrast to these binding protein-dependent transport systems,
the di- and tripeptide carrier DtpT of L. lactis is driven by
the proton motive force and composed of a single polypeptide
of 463 amino acid residues. The DtpT protein has been
shown to be homologous to peptide transport proteins of
Saccharomyces cereVisiae (PTR2) (Perry et al., 1994),
Arabidopsis thaliana (AtPTR2A and AtPTR2B) (Steiner et
al., 1994; Song et al., 1996), rabbit intestine (rbPepT1) (Fei
et al., 1994), human intestine (hPepT1) (Liang et al., 1995),
and Candida albicans (CaPTR2) (Basrai et al., 1995), as well
as a nitrate transport protein of A. thaliana (AtCHL) (Tsay
et al., 1993); this group of proteins has been designated the
peptide transport (PTR) family (Steiner et al., 1995). Align-
ment of the eukaryotic proteins revealed a high number of
identical and similar residues, and conserved glycosylation
and phosphorylation sites, as well as a signature sequence
unique to this group of proteins. The similarity of the
eukaryotic proteins with DtpT is lower and mainly confined
to the N-terminal half. Recently, other genes encoding
eukaryotic peptide transporters [i.e., from kidney and intestine
of rabbit, rat, and man (Boll et al., 1996; Liu et al., 1995;
Miyamoto et al., 1996)] that share characteristics of the PTR
family have been described. The transport proteins PepT2
of rabbit and human kidney have been shown to function as
peptide-H+ symporters (Boll et al., 1996; Liu et al., 1995).
Polytopic cytoplasmic membrane proteins span the mem-
brane in a zigzag manner; the transmembrane segments
(TMSs) are usually predicted to be in an R-helical config-
uration. The orientation of TMSs is, at least in part,
determined by the distribution of the charged residues near
the ends of TMSs. von Heijne has pointed out that short
cytoplasmic loops have more basic residues than would be
expected from a random distribution in hydrophilic regions
of membrane proteins (von Heijne & Gavel, 1988). Thus,
inspection of the aligned sequences and the use of algorithms
to identify membrane-spanning regions allow the construction
of topological models.
To test these models, we have made and analyzed gene
fusions between dtpT and phoA. To support the data
obtained from the protein fusion approach, single cysteine
residues were engineered at selected places in DtpT, and their
accessibility to membrane-impermeant sulfhydryl reagents
was measured. Overall, the results suggest that the predicted
models need adjustment, especially with regard to the
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location and/or orientation of the TMSs at the extremities
of the protein. The activities of the DtpT-reporter fusion
proteins and the pattern of labeling of the cysteine residues
are consistent with a secondary structure model that consists
of 12 TMSs with both N and C termini located intracellularly.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Growth Conditions. Escherichia coli
CC118 (ara D139¢) [ara leu] 7697 ¢lac X74 ¢phoA 20
galE galK thi rspE rpoB argE-[am], recAI) (Calamia &
Manoil, 1990) cells were grown at 37 °C, with vigorous
aeration, in Luria Broth supplemented with carbenicillin (50
íg/mL) when appropriate. The chromogenic reagent 5-bromo-
4-chloro-3-indolyl phosphate (XP) was used as an indicator
of alkaline phosphatase activity and was added at 40 íg/mL
to Luria Broth agar plates. L. lactis AG300 cells were grown
on a chemicaly defined medium (Poolman & Konings, 1988)
at pH 6.4, supplemented with erythromycine (5 íg/mL), plus
1% (w/v) glucose.
General DNA Manipulations. Plasmid DNA was prepared
by the alkaline lysis method as described by Sambrook et
al. (1989). Restriction enzyme digestions were carried out
according to the manufacturer’s recommendations. Ligation
of DNA fragments and transformation were performed as
described by Sambrook et al. (1989). For the exact localiza-
tion of the random fusion points and confirmation of the
sequence of PCR-amplified DNA, the DNA was sequenced
by the dideoxy chain termination method (Sanger et al., 1977)
using T7 DNA polymerase. PCR was performed with VENT
DNA polymerase (New England Biolabs). After 35 cycles
of amplification, the PCR products were purified using the
QIAquick spin PCR purification kit (Qiagen).
Construction of pDT32 and Generation of Random dtpT-
phoA Fusions. Plasmid pDT32 was constructed from pDT3
(Hagting et al., 1994), which contains the dtpT gene under
control of its own promoter. The phoA gene from plasmid
pPHO7 (Gutierrez & Devedjian, 1989) was amplified by
PCR using the forward primer, PhoAfor, containing a
BamHI, SacI, and SmaI site, and the reverse primer, PhoArev,
containing a BamHI, XhoI, and NcoI site (Table 1). The
amplified phoA gene was restricted with BamHI and XhoI
and ligated into BamHI-SalI-digested pDT3. Random
dtpT-phoA fusions were constructed as follows. SacI-
BamHI-digested pDT32 was further digested with exonu-
clease III to create deletions from the 3′ end of dtpT.
Subsequently, the DNA was blunt-ended with S1 nuclease
and ligated. The ligation mixture was transformed to
competent E. coli CC118 cells and plated on LB plates
supplemented with 50 íg/mL carbenicillin plus 40 íg/mL
XP. dtpT-phoA fusions were identified as blue colonies.
Plasmid DNA was isolated, and after restriction analysis,
the fusion point was determined by sequencing using
oligonucleotide PhoA1 (Table 1).
Generation of Site-Specific dtpT-phoA Fusions. Site-
specific dtpT-phoA fusions were made using PCR-amplified
dtpT DNA. For construction of the dtpT-phoA fusions,
DtpTfor3 primer, containing a HindIII site, was used in
combination with several reverse primers that contain a
BamHI restriction site after the codons of interest. The
second multiple cloning site of pPHO7 was removed as a
XhoI-SacI fragment, yielding pPHO7A. After restriction
with HindIII and BamHI, the PCR fragments were ligated
into pPHO7A. The ligation mixtures were used to transform
competent E. coli CC118 cells, which were plated on LB
plates containing carbenicillin (50 íg/mL) plus XP (40 íg/
mL). Plasmid DNA was isolated and sequenced using
oligonucleotide PhoA1.
Enzyme Assays. Alkaline phosphatase (PhoA) activities
were assayed essentially as described (Brickman & Beckwith,
1975). For growth of E. coli cells harboring dtpT-phoA,
single colonies were diluted into 4 mL of LB containing 50
íg/mL carbenicillin and grown until A660 was 0.2-0.7. For
PhoA activities, 1 mL of each culture was centrifuged and
resupended in 1.5 mL of 1 M TRIS-HCl (pH 8.0). The
A660 was measured, and 50 íL of 0.1% SDS and 50 íL of
chloroform were added to 1 mL of the cell suspension.
The tubes were vortexed and incubated for 5 min at 30
°C to permeabilize the cells. The PhoA assay was started
by the addition of 0.1 mL of 0.4% (w/v) p-nitrophenyl
phosphate (Sigma) and stopped by the addition of 0.2 mL
of 1 M potassium hydrogen phosphate. PhoA activity units
were calculated from the absorbance at 420 nm (A420 -
1.75A550  1000)/[time(min)  A660  volume of the cul-
ture assayed (mL)]. All activity values shown are the result
of at least three independent assays; on average, the alka-
line phosphatase activities in these assays varied less than
20%.
Immunoblotting. Part of the samples used for PhoA
activity measurements was subjected to SDS-polyacryl-
amide electrophoresis using 10% polyacrylamide (the samples
were boiled for 5 min in sample buffer prior to loading onto
the gel), after which the proteins were transferred to
polyvinylidene difluoride (PVDF; Millipore) sheets by semi-
dry electroblotting (Kyhse-Anderson, 1984). PhoA hybrid
proteins were detected using a mouse anti-E. coli alkaline
phosphatase monoclonal antibody (Chemicon International
Inc.); alkaline phosphatase-coupled goat anti-mouse IgG was
used as a secondary antibody (Sigma).
Table 1: Oligonucleotides Used for Mutagenesis and Sequencing of the Di- and Tripeptide Transport Gene of L. lactisa
primer mutagenic oligonucleotide characteristics
PhoAfor 5′-CGCGGATCCCGGAGCTCCCGGGCCTGTTCTGGAAAAC BamHI, SacI, SmaI









a Nucleotides in boldface correspond to a restriction site or cysteine mutant.
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Construction of Cysteine Mutants of DtpT. Oligonucle-
otide-directed site-specific mutagenesis was used to generate
single cysteine residues in DtpT; the wild-type DtpT protein
is devoid of cysteines. Cys replacement mutants were
constructed by a two-step PCR method. The synthetic
mutagenic primers used are given in Table 1. The oligo-
nucleotides DtpTrev5 and DtpTcystC, -E, -F, or -G were
used as primers in the first PCR step with plasmid pGKHT
as the template. The pGKHT vector contains the dtpT gene
with additional codons at the 3′ end that specify a six-
histidine tag (A. Hagting et al., unpublished results).
Subsequently, the PCR products were used as a primer in
the second PCR with oligonucleotide DtpTfor6 and plasmid
pGKHT as the template. The resulting 571 bp fragments
were digested with KpnI and BamHI and exchanged with
the equivalent fragment of pGKF52. pGKF52 is a derivative
of pGKF5 (Hagting et al., 1994), in which an approximately
0.8 kb EcoRI-NcoI fragment has been deleted to remove
the KpnI site in the multiple cloning site. The 1180 bp
EcoRI-KpnI and 571 bp KpnI-BamHI fragments of the
mutants were checked by nucleotide sequencing.
Labeling with 3-(N-Maleimidylpropionyl)biocytin. L. lac-
tis AG300 cells (Hagting et al., 1994), expressing the desired
plasmid contruct, were grown on a chemically defined
medium (Poolman & Konings, 1988), supplemented with
erythromycine (5 íg/mL) plus 1% (w/v) glucose, and
harvested at the end exponential phase (A660  0.8). Cells
were washed once with buffer B [50 mM potassium
phosphate (pH 7.5) supplemented with 5 mM MgSO4],
deenergized with 20 mM deoxyglucose for 30 min at 30 °C,
and subsequently washed twice with buffer B. Part of the
cells was incubated with 200 íM 4-acetamido-4′-maleim-
idylstilbene-2,2′-disulfonic acid (AMdiS, Molecular Probes
Inc.) at 30 °C for 30 min to block externally exposed cysteine
residues, followed by two washing steps. AMdiS-treated and
untreated cells were incubated with 100 íM 3-(N-maleim-
idylpropionyl)biocytin (MPB, Molecular Probes Inc.) for 10
min at 30 °C. MPB was added from a 20 mM stock prepared
in dimethyl sulfoxide. The labeling was stopped by the
addition of 10 mM dithiothreitol (DTT), and the cells were
washed twice with buffer B. The cells were resuspended at
an A660 of approximately 50 and treated with 5 mg/mL
lysozyme for 30 min at 30 °C. Subsequently, the protoplasts
were sonicated at an amplitude of 6 ím, using five cycles
of 15 s of sonication and 45 s rest, at 4 °C under a constant
stream of N2. The mixture was centrifuged (15000g,
Eppendorf centrifuge, 15 min), and the supernatant was
collected. The membranes were pelleted by centrifugation
(280000g, 15 min) and resuspended in buffer B. For
maximal labeling with MPB, the probe was added to the
cells prior to sonication; further conditions and handlings
were the same as described above.
The His tag at the C terminus of DtpT was used to partially
purify the DtpT protein. Membranes (2 mg/mL protein) were
solubilized in buffer A [50 mM potassium phosphate (pH
8.0), 10% (v/v) glycerol, and 200 mM NaCl] with 1% (w/v)
n-dodecyl maltoside for 30 min on ice. The insoluble
material was removed by centrifugation (280000g, 15 min),
and the supernatant was mixed and incubated with Ni-NTA
(nitrilotriacetic acid) resin that was equilibrated with buffer
A containing 0.1% (w/v) n-dodecyl maltoside. The Ni-NTA
resin was washed with buffer A containing 0.1% (w/v)
n-dodecyl maltoside plus 15 mM imidazole. The protein
was eluted with buffer A, containing 0.1% (w/v) n-dodecyl
maltoside plus 100 mM imidazole, subjected to SDS-PAGE,
and transferred onto PVDF membranes by semidry elec-
troblotting. Biotinylated proteins were detected using strepta-
vidin-conjugated alkaline phosphatase (Boehringer Man-
nheim); DtpT protein was detected by anti-DtpT polyclonal
antibodies using an alkaline phosphatase-coupled goat anti-
mouse IgG (Sigma) as a secondary antibody.
Transport Assays. [14C]Prolylalanine uptake in L. lactis
AG300 cells, expressing DtpT cysteine mutants, was mea-
sured as previously described (Hagting et al., 1994).
RESULTS
Prediction of the Membrane Topology of the DtpT Protein.
Using the algorithm of Eisenberg et al. (1984), 12 membrane-
spanning regions were predicted by the hydropathy profiling.
A secondary structure model of DtpT based on the hy-
dropathy profile (Figure 1A) and the positive inside rule
suggests a 12-helix bundle protein with the amino and
carboxyl termini located at the outer surface of the membrane
(Figure 1B). Other hydropathy profiling methods [e.g., Klein
et al. (1985)] yielded secondary structure models in which
the locations of the transmembrane segments in the N-
terminal part were predicted differently. To test these
models, dtpT-phoA gene fusions were constructed.
Construction and Analysis of Randomly Generated dtpT-
phoA Fusions. The nested-deletion method was used to
generate gene fusions encoding hybrid proteins with different
portions of the DtpT protein joined to the amino terminus
of alkaline phosphatase. The resulting plasmids were
transformed to E. coli CC118 cells (PhoA-), and blue
colonies were selected on plates containing the chromogenic
substrate 5-bromo-4-chloro-3-indolyl phosphate (XP). The
gene fusions from 23 blue colonies were all found to be in-
frame and corresponded to different portions of DtpT; the
fusion proteins were named by the last amino acid codon
number of DtpT before the fusion point. Plasmid DNA of
a number of white colonies was isolated, and after restriction
analysis, the fusion points were mapped by nucleotide
sequencing, but only out-of-frame fusions were detected. The
fusion points in the plasmids isolated from the blue colonies
were not as randomly distributed as expected (Figure 1B,
circles). For instance, no fusion proteins were found in the
middle or the C-terminal part of the DtpT protein. When
the fusion proteins were investigated for alkaline phosphatase
activity (Table 2), the majority exhibited relatively high levels
of activity as anticipated from their phenotype on XP plates.
The fusion constructs S41, T67, and L343 had PhoA
activities that were lower than expected from their blue
appearance on XP plates. It should be stressed, however,
that the activity was measured in cells that were harvested
at the exponential phase of growth whereas the plate assay
corresponded to stationary phase cells in which the activity
may be higher (van Geest & Lolkema, 1996). All fusion
proteins that had a PhoA activity of >75 are indicated by
filled circles. The fusion proteins that had a quite low
activity, but higher than the control, are indicated by open
circles. Clearly, the position of the fusions in the secondary
structure model suggests the need of major adjustments in
the N-terminal part of the DtpT protein.
E. coli CC118 cells harboring the plasmids with the dtpT-
phoA fusions were subjected to immunoblotting, and hybrid
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proteins were detected using a monoclonal anti-PhoA
antibody. These experiments were performed with the same
batch of E. coli CC118 cells that were used to measure the
alkaline phosphatase activity. In each case, the major band
reacting with the anti-PhoA antibody comigrated with a
molecular mass of approximately 50 kDa, which correlates
with the size of native alkaline phosphatase. In the case of
L12, T13, I30, L37 (Figure 2), A212, and N219 (not shown),
doublet bands the size of native alkaline phosphatase and
the corresponding fusion protein were observed. Comparison
of immunoblot data and the activity measurements (Table
2) indicate that the differences in activity correlate, at least
qualitatively, with variation in expression. It should be
stressed that the activity measurements (e.g., Table 2)
represent the average of three independent experiments,
whereas only the samples of a single experiment are shown
in Figure 2.
Construction and Analysis of Site-Specific dtpT-phoA
Fusions. Since the range of fusions obtained by the nested-
deletion method was unsatisfactory, additional site-specific
fusions with alkaline phosphatase were constructed. To
construct these fusions, the corresponding 5′ region of the
dtpT gene was amplified by PCR and ligated, in-frame, with
the phoA gene. The alkaline phosphatase activity of the 19
DtpT-PhoA fusion proteins varied from 3 to 386 units
(Table 3); the fusions are indicated as squares in Figure 1B
(and Figure 4, see below). Immunodetection of the fusion
proteins with high activity revealed, in most cases, proteolytic
degradation products the size of native alkaline phosphatase.
In general, full length chimeras or degradation products were
barely or not detectable with low-activity fusions [as
observed by others; e.g., Pourcher et al.(1996)].
The results obtained with the fusion proteins with their
junction point in the middle part of the protein (putative
helices IV-XI, Figure 1B) are in good agreement with the
predicted structure. However, the model needs adjustment
in the N- and C-terminal parts of the protein. Using the
algorithm of Klein et al. (1984), a TMS from residue 58 to
74 is predicted, whereas residues 3-21 are not predicted to
form a TMS. The existence of these two TMSs is strongly
suggested by the analysis of the DtpT-PhoA fusions. The
results obtained with the chimeric proteins L394, E430, and
D461 indicate that the model also needs revision in the
C-terminal part of the DtpT protein. One possibility would
be that the putative membrane-spanning segment XII is not
crossing the membrane but is located in the cytoplasm. To
test this hypothesis, single cysteine residues were engineered
in the C-terminal part of the DtpT protein and their
accessibility to membrane-(im)permeant sulfhydryl reagents
was measured.
Biotinylation of Cysteine Residues. Since wild-type DtpT
does not have cysteine residues, cysteines engineered in
putative extracellular or cytoplasmic loops can be used to
determine the membrane sideness of these regions upon
labeling with membrane-impermeant sulfhydryl reagents.
3-(N-Maleimidylpropionyl)biocytin (MPB) is a thiol-specific
compound that may slowly cross the membrane and thereby
label internal and external cysteines, i.e., when used at
relatively high concentrations and/or long incubation times
(Bayer et al., 1985; Loo & Clarke, 1995). 4-Acetamido-4′-
maleimidylstilbene-2,2′-disulfonic acid (AMdiS) possesses
two charged sulfonate groups which makes this probe highly
membrane-impermeable. When single cysteine mutants are
treated with AMdiS, prior to incubation with MPB, cysteines
located in extracellular loops should not become labeled by
MPB, contrary to residues in internal loops. This approach
is even more powerful than the analysis of fusion proteins
when it can be shown that the mutants retain their native
structure, for which retention of function is the best indica-
tion. Uptake experiments confirmed that all mutants take
up radiolabeled prolylalanine at a rate similar to that of wild-
type DtpT (data not shown). To study the membrane
topology, the cysteine mutants were treated with MPB, with
or without pretreatment with AMdiS. After partial purifica-
tion, the His-tagged proteins were subjected to SDS-PAGE
and immunoblotting, and the amount of DtpT protein was
Table 2: Alkaline Phosphatase Activity of Randomly Generated
DtpT-PhoA Hybrid Proteinsa
fusiona PhoA activity fusiona PhoA activity
L12 127 F87 404
T13 135 E272 278
G19 152 T276 626
L22 287 A279 459
A27 473 V280 823
I30 400 W281 343
A36 614 D300 806
L37 306 L310 300
S41 60 F311 267
T67 12 L343 16
A85 577 S361 163
L86 550 vector control 2
a Amino acid in the DtpT protein that precedes the fusion point.
FIGURE 2: Immunoblot analysis of randomly generated DtpT-
PhoA chimeras. E. coli CC118 cells containing the plasmids
encoding DtpT-PhoA fusion proteins were grown in LB containing
50 íg/mL carbenicillin. The total cell protein (30 íg) was subjected
to 10% SDS-PAGE, electroblotted, and visualized as described
in Experimental Procedures.
Table 3: Alkaline Phosphatase Activities of the DtpT-PhoA
Hybrid Proteins Generated by Site-Specific Mutagenesis
PhoA activity PhoA activity
fusiona units classb fusiona units classb
Y34 18 L L260 4 L
G54 7 L E271 48 I
L73 353 H L288 125 H
R115 12 L G327 3 L
T139 386 H L357 98 H
L148 211 H S365 242 H
R177 14 L L394 71 I
A212 210 H E430 32 I
N219 188 H D461 4 L
V246 19 L vector 2 L
a Last amino acid in the DtpT protein that precedes the fusion point.
b H, I, and L indicate high (PhoA of >75 u), intermediate (PhoA
between 25 and 75 u), and low (PhoA of <25 u) activities, respectively.
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determined with an anti-DtpT polyclonal antibody. The
variations in the amount of DtpT were less than 2-fold
(Figure 3B). Figure 3A shows that cells expressing mutant
T360C were biotinylated (lane 2) and that the biotinylation
of this mutant was blocked by pretreatment with AMdiS.
These results are consistent with T360C being located at the
extracellular surface. By contrast, biotinylation of whole
cells expressing mutants L394C, F425C, and V462C was
barely or not detectable. To test whether these cysteines
can react with MPB, the cells were sonicated prior to
labeling. Biotinylation of the mutants T360C, F425C, and
V462C was detected (Figure 3, lanes 3), whereas mutant
L394C was not accessible to labeling by MPB. The lack of
biotinylation of F425C and V462C in intact cells can be due
to slow membrane penetration of MPB into the cells and/or
to a decrease of the free MPB concentration at the inside as
a result of reaction with intracellular thiol compounds. In
both cases, the data strongly suggest that these residues are
located at the cytoplasmic face of the membrane. This
confirms the suggestion that the last putative membrane-
spanning segment does not cross the membrane.
DISCUSSION
In this study, we report on the membrane topology of the
L. lactis di- and tripeptide transporter. Since this protein is
homologous to a large family of eukaryotic (peptide)
transporters, the topology studies have implications for the
predicted secondary structure of these proteins as well (see
below). To verify the predictions made regarding the
locations of the transmembrane segments and their orienta-
tion in the membrane, we constructed and analyzed gene
fusions of dtpT with alkaline phosphatase (phoA). The
results obtained from several fusions are not in agreement
with the predicted secondary structure model of DtpT, in
particular regarding the N- and C-terminal TMSs (Figure
1B). For the analysis, we assume that a high PhoA activity
corresponds to a periplasmic location and/or a location of
the fusion point in the outer leaflet of the membrane. Fusions
with intermediate activities are positioned in the middle of
the membrane, whereas low PhoA activities are assumed to
reflect a fusion point in the cytoplasm or one in the inner
leaflet of the membrane. Using these criteria, a residue
number of 19 for the TMSs and an overall hydrophobicity
of >0.5 [based on the algorithm of Eisenberg et al. (1984)],
a new structure model can be constructed that is consistent
with the experimental data (Figure 4). The revised secondary
structure model shows that the polypeptide crosses the
membrane 12 times but that several TMSs are in a different
position compared to that in the predicted model (Figure 1B),
and that the N and C termini are located intracellularly. In
the revised model, all fusions with a high alkaline phos-
phatase activity (except for Y34) are found in external loops
or in the outer halves of putative TMSs.
Fusion proteins G54 and T67 exhibit low alkaline phos-
phatase activities but are predicted to be in a putative
periplasmic loop when the algorithm of Eisenberg and the
positive inside rule are used. When the algorithm of Klein
et al. (1985) is used, the predictions for the carboxyl-terminal
part are the same as those obtained by the Eisenberg method,
but the TMSs in the amino-terminal part are arranged
differently. The model in Figure 1B shows a long hydro-
phobic stretch from amino acid residue 52 to 103, whereas
the algorithm of Klein et al. (1985) predicts more clearly
two putative TMSs for this region. The introduction of an
extra TMS in this region results in an intracellular location
of the amino terminus and a repositioning of the high activity
fusions to the outer half of the cytoplasmic membrane (Figure
4). This modification of the membrane topology is strongly
suggested by the fusion proteins L12, T13, G19, L22, A27,
I30, A36, L37, S41, G54, and T67.
Fusion D461, which is constructed two residues away from
the C terminus, exhibits a low alkaline activity, which
suggests that, consistent with the new model (Figure 4), the
C terminus is located in the cytoplasm; the original model
(Figure 1B) predicts that the C terminus is in the periplasm.
Fusion protein E430 exhibits intermediate alkaline phos-
phatase activity, which may be caused by the loss of several
positively charged residues in the C-terminal end. Also in
other cases, the absence of carboxyl-terminal sequences has
lead to anomalous findings in the membrane topology (Boyd
& Beckwith, 1989; Lee & Manoil, 1996). The anomalies
can result from the fact that basic amino acid residues found
in cytoplasmic loop regions play a prominent role as
topological determinants. When PhoA is fused to a residue
that precedes basic ones, it is less stably localized in the
cytoplasm than if it follows these positively charged residues.
The former class of fusions may exhibit higher alkaline
phosphatase activities than expected. To obtain further
support for the suggestion that the C-terminal end is indeed
located in the cytoplasm, we constructed a series of single
cysteine mutants and assessed the membrane sideness of
these residues by labeling studies with MPB. The results
obtained from these studies are in accordance with the
hypothesis that the C terminus is located in the cytoplasm.
Therefore, we conclude that the last predicted transmembrane
segment (residues 433-451) of DtpT is not crossing the
membrane, although the hydrophobicity and amphipathy of
this region are quite high.
Fusion protein L394 exhibits an intermediate alkaline
phosphatase activity, which is 2-fold higher than the ac-
tivity of E430, but is predicted to be located in a cytoplasmic
loop (Figure 1B). Using a sliding window of 19 and the
algorithm of Eisenberg et al. (1984), the region from 392 to
410 could form a putative TMS (overall hydrophobicity of
0.41). When this region forms TMS XII, residue L394 can
FIGURE 3: Labeling and immunological detection of DtpT Cys
mutants. L. lactis AG300 cells carrying plasmids containing the
single cysteine mutants of dtpT were labeled with MPB with (1)
or without (2) pretreatment with AMdiS. To make intracellularly
located cysteines accessible for the maleimide, the cells were
sonicated in the presence of MPB (3). The partially purified DtpT
proteins were subjected to SDS-PAGE, electroblotted, and visual-
ized by streptavidin-conjugated alkaline phosphatase (A) or anti-
DtpT polyclonal antibodies (B).
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be accommodated in the periplasmic half of the membrane
(Figure 4).
Immunoblot data indicate that the variation in alkaline
phosphatase activity of the fusion proteins with their junction
points in the periplasmic half of a transmembrane domain
or in a periplasmic loop correlates qualitatively with differ-
ences in hybrid protein expression. Low-activity fusion
proteins are barely or not detected by the Western analysis.
Their fusion points are predicted to be in the cytoplasmic
half of a TMS or in a cytoplasmic loop These observations
are consistent with previous findings (Calamia & Manoil,
1990; Go¨tt & Boos, 1988; Lloyd & Kadner, 1990; Pourcher
et al., 1996; Ujwal et al., 1995) and most likely reflect the
lack of essential intrachain disulfide bonds, which cannot
be formed in the reducing environment of the cytoplasm,
thereby making PhoA highly susceptible to proteolytic
degradation (Derman & Beckwith, 1991).
In addition to alkaline phosphatase being the positive
reporter of a periplasmic location, we have used â-galac-
tosidase as a complementary positive reporter of a cytoplas-
mic location. The fusion points were identical to those
shown in Table 3. Even though the data obtained from the
fusions in putative internal loops were entirely consistent
with the PhoA data (i.e., high â-galactosidase activities), four
DtpT-LacZ fusions, which are most likely in an external
loop (L148, N219, L288, and S365), had an unexpected high
â-galactosidase activity. In these cases, the liberation of an
initially membrane-embedded and enzymatically inactive
â-galactosidase portion may have resulted in the formation
of active tetramers. In this regard, it is worth noting that
these four fusions have a relatively large hydrophilic loop
between the last TMS and the LacZ moiety which may have
prevented the translocation. Similar anomalies have been
observed by others (Chepuri & Gennis, 1990; Eithinger &
Friedrich, 1994; Go¨tt and Boos, 1988), which clearly limits
the reliability of LacZ as a compartment-specific reporter.
Although sequence comparisons of DtpT and other puta-
tive peptide transport proteins have been reported by Steiner
et al. (1995), the sequence alignments were not optimized.
Moreover, many more homologous proteins have been
described in the past years, including three other mammalian
peptide transporters (hPepT2 and rbPepT2 from human and
rabbit kidney, respectively, and rPepT1 from rat small
intestine), two proteins with unknown function from Cae-
norhabditis elegans, a putative nitrate transporter from
Brassica napus (RCH2), and the products of yjdL and yhiP
in E. coli. Recently, we cloned and sequenced the dtpT gene
of L. helVeticus (H. Nakajima et al., unpublished results), of
which the deduced polypeptide is 34% identical to DtpT of
L. lactis. Part of the multiple sequence alignment of DtpT
and most of its homologues are shown in Figure 5; when
sequences are nearly identical, only one of the proteins is
shown in the alignment. The alignments were optimized by
minimizing the number of gaps. The proposed positions of
the TMSs were adjusted in light of the experimental data
obtained in this study and predictions made by the algorithm
of Eisenberg et al. (1984). The similarity of all members of
the PTR family is highest in the N-terminal portion of the
proteins, and the membrane topology of DtpT is likely to
reflect that of the other proteins as well. There is, however,
some ambiguity in assigning the position of TMS I. It is
particularly difficult to define TMS I in PTR2, CaPTR2,
CePepTa, and AtPTR2B due to the large number of
hydrophilic/charged residues throughout the point where
FIGURE 4: Secondary structure model of the di- and tripeptide transport protein DtpT. The model is based on hydropathy profiling, the
activity of the DtpT-PhoA fusions, and the labeling pattern of single cysteine mutants. All other symbols are the same as in the legend to
Figure 1. The dark shaded stretch indicates a TMS with an overall hydrophobicity of 0.41; the arrows indicate the position at which the
single cysteines were engineered.
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TMS II is indicated (Figure 5). On the basis of the
membrane topology of DtpT, we propose that TMS I, as
defined in Figure 5, is also present in the eukaryotic members
of the PTR family. Although it is energetically unfavorable
to have charged residues in the hydrophobic membrane
environment, it is possible that these residues in TMS I form
ion pairs with residues in other TMSs, thereby stabilizing
the overall structure of the protein. Alternatively, these
residues may have important catalytic functions, but the poor
sequence conservation in this region argues against this
possibility.
Hydropathy profiling of the mammalian peptide transport-
ers predicts a large loop of approximately 200 amino acid
residues between TMSs IX and X. This loop probably
represents the target for N-linked glycosylation and is thus
predicted to be extracellular (Fei et al., 1994). This loop
region is also present in the C. elegans proteins but not in
the transporters from yeast (PTR2 and CaPTR2), plant
(AtPTR2A, AtPTR2B, and AtCHL), B. napus (RCH2), and
bacteria. Similarity in sequence and hydropathy is also found
in the three C-terminal TMSs of all eukaryotic PTR proteins
(not shown), which is suggestive of a similar membrane
topology. The prokaryotic proteins, YjdL, YhiP, DtpTLL,
and DtpTLH, are very different from the eukaryotic mem-
bers of the PTR family in their C-terminal halves. The
hydropathy profile of YjdL and YhiP suggests a membrane
topology that is very similar to that of DtpT, except that
there are additional TMSs predicted in the C-terminal part.
In conclusion, the sequence comparisons suggest that the
membrane topology of the members of the PTR family is
similar for the N-terminal halves and that the experimental
data obtained for DtpT may be used to refine the secondary
structure models of the other proteins. The similarity in
sequence is highest in the part between TMS II and VI, which
also contains the signature motif of the PTR family F-S/T/
N/M-X-F-V/Y/F-h-X-I-N-h-G-S/A-h (h indicates a hydro-
phobic residue). The function of this motif is unknown, but
it likely plays an important role in the transport process.
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